Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.53 |
| ▸ | TSHR | P16473 | 3/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.35 |
| ▸ | STAT3 | P40763 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | TAS2R46 | P59540 | 4/20 | 0.31 |
| ▸ | TAS2R31 | P59538 | 2/20 | 0.31 |
| ▸ | TAS2R10 | Q9NYW0 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3921676 | 0.84 | LMNA (0.50) | LMNATSHRTRPA1ALOX15CYP3A4 | |
| SCHEMBL4472607 | 0.80 | LMNA (0.55) | LMNATSHRTRPA1ALOX15CYP3A4 | |
| SCHEMBL4740720 | 0.80 | LMNA (0.55) | LMNATSHRTRPA1ALOX15CYP3A4 | |
| SCHEMBL3922725 | 0.79 | LMNA (0.47) | LMNATSHRTRPA1ALOX15CYP3A4 | |
| SCHEMBL3920715 | 0.78 | LMNA (0.43) | LMNATSHRTRPA1ALOX15CYP3A4 | |
| SCHEMBL10831405 | 0.77 | LMNA (0.51) | LMNATSHRTRPA1ALOX15CYP3A4 | |
| (-)-Limonene SCHEMBL17204330 | 0.74 | LMNA (0.77) | LMNATSHRTRPA1ALOX15CYP3A4 | |
| SCHEMBL12909964 | 0.73 | LMNA (0.66) | LMNATSHRTRPA1ALOX15CYP3A4 | |
| SCHEMBL1037667 | 0.73 | LMNA (0.60) | LMNATSHRTRPA1ALOX15CYP3A4 | |
| SCHEMBL937050 | 0.73 | LMNA (0.60) | LMNATSHRTRPA1ALOX15CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1485350-B1 | USE OF UNSATURATED KETONES AS A PERFUME | KAO CORP (JP) | 2013-07-17 | — | — | EP | disclosed |
| US-7582600-B2 | Use of unsaturated ketones as a perfume | KAO CORPORATION (JP) | 2009-09-01 | — | — | US | disclosed |
| US-20090054299-A1 | USE OF UNSATURATED KETONES AS A PERFUME | KAO CORPORATION (JP) | 2009-02-26 | — | — | US | disclosed |
| US-20050119158-A1 | Use of unsaturated ketones as a perfume | PROVIDENT BANK | 2005-06-02 | — | — | US | disclosed |
| EP-1485350-A1 | USE OF UNSATURATED KETONES AS A PERFUME | Kao Corporation (JP) | 2004-12-15 | — | — | EP | disclosed |
| WO-2003078391-A1 | USE OF UNSATURATED KETONES AS A PERFUME | KAO CORPORATION (JP) | 2003-09-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050119158-A1 | Use of unsaturated ketones as a perfume | FAAH, FAAH2, FASN | LMNA 1511/4885TSHR 1702/4885TRPA1 342/4885 |
| US-20090054299-A1 | USE OF UNSATURATED KETONES AS A PERFUME | FFAR3, FFAR1, FASN | LMNA 1417/4885TSHR 1794/4885TRPA1 469/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.